from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1520/-

LFCtreatmentdescriptionclass of inhibitor

0.471

Amikacinug/mL Amikacintranslation

0.507

Cap5-10ug/mL Capreomycintranslation

1.516

Rox10-50 ug/mL Roxithromycintranslation

0.049

SM2-5 ug/mL Streptomycintranslation

1.277

Tet5-10 ug/mL Tetracyclinetranslation

0.112

Rif0.2-5ug/mL Rifampicintranscription

-0.257

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.990

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.009

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.224

CPZ10-50 ug/mL Chlorpromazinerespiration

1.783

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.095

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.367

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.023

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.270

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.409

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.578

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.232

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.462

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.258

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.430

KCN5-20 ug/mL Potassium cyaniderespiration

-0.831

NaN30.2-2 mM Sodium aziderespiration

-0.559

Nigericin50 uM Nigericinrespiration

-0.451

TRC10-150 ug/mL Triclosanrespiration

0.149

TRZ10-25 ug/mL Thioridazinerespiration

1.128

Valinomycin0.5-10 uM Valinomycinrespiration

1.764

ZnSO42 mM ZnSO4respiration

-1.685

menadione6-10 ug/mL Menadionerespiration

1.106

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

1.012

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

1.596

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.308

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

2.400

NRP_1Non-replicating persistence stage 1dosRassociated

0.145

Amp0.2mg/mL AmpicillincellWall

-0.306

Cephalexin20-100 ug/mL CephalexincellWall

0.262

Cerulenin0.32-5 ug/mL CerulenincellWall

0.076

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.101

EMB10-20 ug/mL EthambutolcellWall

-0.442

Eta12-40 ug/mL EthionamidecellWall

-0.730

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.174

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.214

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.369

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.305

BZA0.12 mg/mL BenzamidearomaticAmides

0.113

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.346

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.582

H2O24 mM hydrogen peroxideDNAdamaging

-0.099

Levo10 ug/mL LevofloxacinDNAdamaging

0.471

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.995

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.160

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.367

UVUV-irradiationDNAdamaging

0.843

ARP41-4 ug/mL Antitubercular compound ARP4?

0.442

Antimycin12.5-50 ug/mL Antimycin A?

-0.018

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.434

PA_110-50 ug/mL Antitubercular compound PA-1?

0.279

PA_2110-50 ug/mL Antitubercular compound PA-21?

-2.449

PA8240.2-2 ug/mL PA-824?

-2.035

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.443

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.106

Verapamil50 uM Verapamil?

-0.026

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.069

methoxatin10-20 ug/mL Methoxatin?